Please check your internet connection and try again.
## Clobazam (Oral Formulation)
### Overview
Clobazam is a benzodiazepine derivative used as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age and older. It possesses anticonvulsant, sedative, and anxiolytic properties.
### Primary Indications
* Adjunctive treatment of seizures in patients with Lennox-Gastaut Syndrome (LGS), aged 2 years and older.
### Adult Dosing
* **Initiation:** Typically starts at 5 mg twice daily.
* **Titration:** Can be increased by 5-10 mg every week, divided into two doses.
* **Maintenance:** Usual effective dose is 10-20 mg twice daily.
* **Maximum Dose:** Do not exceed 30 mg twice daily. Doses may be adjusted by the prescriber based on clinical response and tolerability.
### Pediatric Dosing (2 to <10 years of age)
* **Initiation:** Typically starts at 5 mg once daily.
* **Titration:** Can be increased by 2.5-5 mg every week, divided into two doses.
* **Maintenance:** Usual effective dose is 5-10 mg twice daily.
* **Maximum Dose:** Do not exceed 10 mg twice daily. Doses may be adjusted by the prescriber based on clinical response and tolerability.
### Pediatric Dosing (10 to <18 years of age)
* **Initiation:** Typically starts at 5 mg twice daily.
* **Titration:** Can be increased by 5-10 mg every week, divided into two doses.
* **Maintenance:** Usual effective dose is 10-20 mg twice daily.
* **Maximum Dose:** Do not exceed 20 mg twice daily. Doses may be adjusted by the prescriber based on clinical response and tolerability.
### Dose Adjustments
* **Hepatic Impairment:** Use with caution. No specific dose adjustment guidelines are established, but lower doses may be warranted due to reduced metabolism.
* **Renal Impairment:** Use with caution. No specific dose adjustment guidelines are established.
### Contraindications
* Known hypersensitivity to clobazam or other benzodiazepines.
### Adverse Effects
* **Common:** Somnolence, sedation, ataxia, fatigue, drooling, constipation, decreased appetite, irritability, aggression, respiratory depression.
* **Serious:** Suicidal behavior and ideation, severe drowsiness, withdrawal symptoms (insomnia, anxiety, agitation, tremors, hallucinations), paradoxical reactions.
### Key Drug Interactions
* **CNS Depressants (e.g., alcohol, opioids, other sedatives):** Additive CNS depression; increased risk of sedation, respiratory depression.
* **CYP3A4 Inhibitors (e.g., ketoconazole, itraconazole, clarithromycin):** May increase clobazam plasma concentrations, increasing risk of adverse effects.
* **CYP3A4 Inducers (e.g., rifampin, carbamazepine, phenytoin):** May decrease clobazam plasma concentrations, potentially reducing efficacy.
* **Other Anticonvulsants:** Monitor for additive CNS depression and potential changes in efficacy.
### Monitoring
* Monitor for signs of excessive sedation, respiratory depression, and paradoxical reactions.
* Assess for signs and symptoms of suicidal behavior and ideation.
* Monitor for withdrawal symptoms upon discontinuation.
* Therapeutic drug monitoring may be considered in specific situations, particularly with interacting medications.
### Clinical Pearls
* Clobazam is typically used as adjunctive therapy; abrupt discontinuation can precipitate seizures. Tapering is recommended.
* Due to its long half-life, accumulation can occur, especially with higher doses or in patients with impaired hepatic function.
* There is a risk of dependence and abuse.
* Oral suspension contains sorbitol and may not be suitable for patients with hereditary fructose intolerance.
***
*This information is intended for clinical use and does not replace professional medical advice. Always verify current prescribing information and consult relevant guidelines before making treatment decisions.*
